Literature DB >> 11751858

Structure, specificity, and mode of interaction for bacterial albumin-binding modules.

Maria U Johansson1, Inga-Maria Frick, Hanna Nilsson, Per J Kraulis, Sophia Hober, Per Jonasson, Martin Linhult, Per-Ake Nygren, Mathias Uhlén, Lars Björck, Torbjörn Drakenberg, Sture Forsén, Mats Wikström.   

Abstract

We have determined the solution structure of an albumin binding domain of protein G, a surface protein of group C and G streptococci. We find that it folds into a left handed three-helix bundle similar to the albumin binding domain of protein PAB from Peptostreptococcus magnus. The two domains share 59% sequence identity, are thermally very stable, and bind to the same site on human serum albumin. The albumin binding site, the first determined for this structural motif known as the GA module, comprises residues spanning the first loop to the beginning of the third helix and includes the most conserved region of GA modules. The two GA modules have different affinities for albumin from different species, and their albumin binding patterns correspond directly to the host specificity of C/G streptococci and P. magnus, respectively. These studies of the evolution, structure, and binding properties of the GA module emphasize the power of bacterial adaptation and underline ecological and medical problems connected with the use of antibiotics.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11751858     DOI: 10.1074/jbc.M109943200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Binding of albumin promotes bacterial survival at the epithelial surface.

Authors:  Arne Egesten; Inga-Maria Frick; Matthias Mörgelin; Anders I Olin; Lars Björck
Journal:  J Biol Chem       Date:  2010-11-22       Impact factor: 5.157

2.  Albumin-binding domain conjugate for near-infrared fluorescence lymphatic imaging.

Authors:  Cynthia A Davies-Venn; Bonnie Angermiller; Nathaniel Wilganowski; Pradip Ghosh; Barrett R Harvey; Grace Wu; Sunkuk Kwon; Melissa B Aldrich; Eva M Sevick-Muraca
Journal:  Mol Imaging Biol       Date:  2012-06       Impact factor: 3.488

3.  Conjugate of Doxorubicin to Albumin-Binding Peptide Outperforms Aldoxorubicin.

Authors:  Parisa Yousefpour; Lucie Ahn; Joel Tewksbury; Soumen Saha; Simone A Costa; Joseph J Bellucci; Xinghai Li; Ashutosh Chilkoti
Journal:  Small       Date:  2019-02-13       Impact factor: 13.281

4.  Biodistribution of a bispecific single-chain diabody and its half-life extended derivatives.

Authors:  Roland Stork; Emmanuelle Campigna; Bruno Robert; Dafne Müller; Roland E Kontermann
Journal:  J Biol Chem       Date:  2009-07-23       Impact factor: 5.157

5.  An artificially evolved albumin binding module facilitates chemical shift epitope mapping of GA domain interactions with phylogenetically diverse albumins.

Authors:  Yanan He; Yihong Chen; David A Rozak; Philip N Bryan; John Orban
Journal:  Protein Sci       Date:  2007-06-13       Impact factor: 6.725

6.  Development and characterization of small bispecific albumin-binding domains with high affinity for ErbB3.

Authors:  Johan Nilvebrant; Mikael Astrand; John Löfblom; Sophia Hober
Journal:  Cell Mol Life Sci       Date:  2013-06-02       Impact factor: 9.261

7.  Structural basis for the binding of naproxen to human serum albumin in the presence of fatty acids and the GA module.

Authors:  Sara Lejon; Jacob Flyvholm Cramer; Peter Nordberg
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-01-18

8.  Engineering bispecificity into a single albumin-binding domain.

Authors:  Johan Nilvebrant; Tove Alm; Sophia Hober; John Löfblom
Journal:  PLoS One       Date:  2011-10-03       Impact factor: 3.240

9.  Complete genome sequence of Finegoldia magna, an anaerobic opportunistic pathogen.

Authors:  Takatsugu Goto; Atsushi Yamashita; Hideki Hirakawa; Minenosuke Matsutani; Kozo Todo; Kenshiro Ohshima; Hidehiro Toh; Kazuaki Miyamoto; Satoru Kuhara; Masahira Hattori; Tohru Shimizu; Shigeru Akimoto
Journal:  DNA Res       Date:  2008-02-07       Impact factor: 4.458

10.  Comparative Preclinical Evaluation of HER2-Targeting ABD-Fused Affibody® Molecules 177Lu-ABY-271 and 177Lu-ABY-027: Impact of DOTA Position on ABD Domain.

Authors:  Yongsheng Liu; Anzhelika Vorobyeva; Tianqi Xu; Anna Orlova; Annika Loftenius; Theresa Bengtsson; Per Jonasson; Vladimir Tolmachev; Fredrik Y Frejd
Journal:  Pharmaceutics       Date:  2021-06-07       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.